Filip Farnebo

About me
Publications
CV
Public outreach and news

Research

Research group leader of the group Reconstructive Plastic Surgery [1]
[1] http://ki.se/en/mmk/reconstructive-plastic-surgery-0

Articles

Article: JACC-BASIC TO TRANSLATIONAL SCIENCE. 2022;7(3):193-204

Erythrocytes Induce Vascular Dysfunction in COVID-19.

Mahdi A; Collado A; Tengbom J; Jiao T; Wodaje T; Johansson N; Farnebo F; Färnert A; Yang J; Lundberg JO; Zhou Z; Pernow J
Article: PLASTIC AND RECONSTRUCTIVE SURGERY - GLOBAL OPEN. 2021;9(7):e3628

Improved Surgical Outcome with Double Incision and Free Nipple Graft in Gender Confirmation Mastectomy.

Kamali A; Sigurjónsson H; Gran I; Farnebo F; Conneryd Lundgren K; Granath F; Sommar P
Article: JOURNAL OF CRANIOFACIAL SURGERY. 2019;30(5):1383-1386

Management of the Midface in the Transgender Patient.

Natghian H; Farnebo F; Lundgren KC
Article: JOURNAL OF CRANIOFACIAL SURGERY. 2017;28(2):391-393

Lower Eyelid Complications in Facial Fracture Surgery.

Neovius E; Clarliden S; Farnebo F; Lundgren TK
Article: JOURNAL OF SEXUAL MEDICINE. 2017;14(2):269-273

Long-Term Sensitivity and Patient-Reported Functionality of the Neoclitoris After Gender Reassignment Surgery.

Sigurjónsson H; Möllermark C; Rinder J; Farnebo F; Lundgren TK
Article: EUROPEAN JOURNAL OF PLASTIC SURGERY. 2017;40(3):223-226

Quality of life improves early after gender reassignment surgery in transgender women.

Lindqvist EK; Sigurjonsson H; Möllermark C; Rinder J; Farnebo F; Lundgren TK
Article: PLASTIC AND RECONSTRUCTIVE SURGERY - GLOBAL OPEN. 2017;5(1):e1210

Midface Osteotomies for Feminization of the Facial Skeleton.

Lundgren TK; Farnebo F
Article: JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY. 2017;70(1):120-126

Long-term sensory disturbances after orbitozygomatic fractures.

Neovius E; Fransson M; Persson C; Clarliden S; Farnebo F; Lundgren TK
Article: PLASTIC AND RECONSTRUCTIVE SURGERY - GLOBAL OPEN. 2016;4(6):e767

Solely Penile Skin for Neovaginal Construction in Sex Reassignment Surgery.

Sigurjonsson H; Rinder J; Lindqvist EK; Farnebo F; Lundgren TK
Article: JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY. 2015;68(2):219-225

Persistent diplopia after fractures involving the orbit related to nerve injury.

Neovius E; Fransson M; Matthis SP; Persson C; Östlund S; Farnebo F; Lundgren TK
Article: STEM CELLS AND DEVELOPMENT. 2013;22(9):1360-1369

Hypoxia-induced arterial differentiation requires adrenomedullin and notch signaling.

Lanner F; Lee KL; Ortega GC; Sohl M; Li X; Jin S; Hansson EM; Claesson-Welsh L; Poellinger L; Lendahl U; Farnebo F
Article: APMIS. 2012;120(10):786-793

Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.

Schennings T; Farnebo F; Szekely L; Flock J-I
Article: JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY. 2010;63(11):1910-1916

Endothelial activation with prothrombotic response in irradiated microvascular recipient veins.

Halle M; Ekström M; Farnebo F; Tornvall P
Article: JOURNAL OF CELL SCIENCE. 2010;123(Pt 17):2931-2942

Control of Notch-ligand endocytosis by ligand-receptor interaction.

Hansson EM; Lanner F; Das D; Mutvei A; Marklund U; Ericson J; Farnebo F; Stumm G; Stenmark H; Andersson ER; Lendahl U
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2010;55(12):1227-1236

Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries.

Halle M; Gabrielsen A; Paulsson-Berne G; Gahm C; Agardh HE; Farnebo F; Tornvall P
Article: STEM CELLS. 2010;28(2):191-200

Heparan sulfation-dependent fibroblast growth factor signaling maintains embryonic stem cells primed for differentiation in a heterogeneous state.

Lanner F; Lee KL; Sohl M; Holmborn K; Yang H; Wilbertz J; Poellinger L; Rossant J; Farnebo F
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2010;391(1):24-27

Sp1 mediate hypoxia induced ephrinB2 expression via a hypoxia-inducible factor independent mechanism.

Sohl M; Lanner F; Farnebo F
Article: GENE. 2009;437(1-2):54-59

Characterization of the murine Ephrin-B2 promoter.

Sohl M; Lanner F; Farnebo F
Article: CARDIOVASCULAR RESEARCH. 2009;82(1):107-114

Cardioprotection by hypoxia-inducible factor 1 alpha transfection in skeletal muscle is dependent on haem oxygenase activity in mice.

Czibik G; Sagave J; Martinov V; Ishaq B; Sohl M; Sefland I; Carlsen H; Farnebo F; Blomhoff R; Valen G
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(2):389-394

Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.

Geli J; Kogner P; Lanner F; Natalishvili N; Juhlin C; Kiss N; Clark GJ; Ekström TJ; Farnebo F; Larsson C
Article: CLINICAL INFECTIOUS DISEASES. 2008;47(2):E11-E16

Late-onset posttraumatic skin and soft-tissue infections caused by rapid-growing mycobacteria in tsunami survivors.

Appelgren P; Farnebo F; Dotevall L; Studahl M; Jönsson B; Petrini B
Article: CIRCULATION RESEARCH. 2008;102(12):1483-1491

Notch signaling regulates platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells.

Jin S; Hansson EM; Tikka S; Lanner F; Sahlgren C; Farnebo F; Baumann M; Kalimo H; Lendahl U
Article: STEM CELLS. 2007;25(12):2987-2995

Lentiviral rescue of vascular endothelial growth factor receptor-2 expression in flk1-/- embryonic stem cells shows early priming of endothelial precursors.

Li X; Edholm D; Lanner F; Breier G; Farnebo F; Dimberg A; Claesson-Welsh L
Article: ENDOCRINE-RELATED CANCER. 2007;14(1):125-134

The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.

Geli J; Kiss N; Lanner F; Foukakis T; Natalishvili N; Larsson O; Kogner P; Höög A; Clark GJ; Ekström TJ; Bäckdahl M; Farnebo F; Larsson C
Article: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 2007;27(3):487-493

Functional arterial and venous fate is determined by graded VEGF signaling and notch status during embryonic stem cell differentiation.

Lanner F; Sohl M; Farnebo F
Article: EXPERIMENTAL CELL RESEARCH. 2007;313(2):284-291

Consequences of Shb and c-Abl interactions for cell death in response to various stress stimuli.

Hägerkvist R; Mokhtari D; Lindholm C; Farnebo F; Mostoslavsky G; Mulligan RC; Welsh N; Welsh M
Article: MEDICAL MYCOLOGY. 2006;44(2):189-192

Concomitant late soft tissue infections by Cladophialophora bantiana and Mycobacterium abscessus following tsunami injuries.

Petrini B; Farnebo F; Hedblad M-A; Appelgren P
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004;101(32):11658-11663

Dose-dependent response of FGF-2 for lymphangiogenesis.

Chang LK; Garcia-Cardeña G; Farnebo F; Fannon M; Chen EJ; Butterfield C; Moses MA; Mulligan RC; Folkman J; Kaipainen A
Article: CANCER BIOLOGY & THERAPY. 2002;1(5):548-553

Gene therapy of prostate cancer with the soluble vascular endothelial growth factor receptor Flk1.

Becker CM; Farnebo FA; Iordanescu I; Behonick DJ; Shih M-C; Dunning P; Christofferson R; Mulligan RC; Taylor GA; Kuo CJ; Zetter BR
Article: CLINICAL ENDOCRINOLOGY. 2002;56(2):261-269

Genetic and clinical characterization of sporadic cystic parathyroid tumours.

Villablanca A; Farnebo F; Teh BT; Farnebo L-O; Höög A; Larsson C
Article: CLINICAL ENDOCRINOLOGY. 2002;56(2):259-267

Genetic and clinical characterization of sporadic cystic parathyroid tumours

Villablanca A; Farnebo F; Teh BT; Farnebo LO; Höög A; Larsson C
Article: KIDNEY INTERNATIONAL. 2001;60(5):1666-1675

Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.

Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2001;145(4):415-420

Homozygous inactivation of the MEN1 gene as a specific somatic event in a case of secondary hyperparathyroidism.

Forsberg L; Villablanca A; Välimäki S; Farnebo F; Farnebo LO; Lagercrantz S; Larsson C
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2001;66(5):297-304

Identification of numerical and structural chromosome aberrations in 15 high hyperdiploid childhood acute lymphoblastic leukemias using spectral karyotyping.

Nordgren A; Farnebo F; Johansson B; Holmgren G; Forestier E; Larsson C; Söderhäll S; Nordenskjöld M; Blennow E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2001;98(8):4605-4610

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.

Kuo CJ; Farnebo F; Yu EY; Christofferson R; Swearingen RA; Carter R; von Recum HA; Yuan J; Kamihara J; Flynn E; D'Amato R; Folkman J; Mulligan RC
Article: CANCER GENETICS. 2001;126(1):1-7

Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping.

Rummukainen J; Kytölä S; Karhu R; Farnebo F; Larsson C; Isola JJ
Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;6(4):469-474

Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas.

Edström E; Frisk T; Farnebo F; Höög A; Bäckdahl M; Larsson C
Article: AMERICAN JOURNAL OF PATHOLOGY. 2000;157(2):579-586

Patterns of chromosomal imbalances in parathyroid carcinomas.

Kytölä S; Farnebo F; Obara T; Isola J; Grimelius L; Farnebo LO; Sandelin K; Larsson C
Article: CLINICAL ENDOCRINOLOGY. 2000;53(1):85-92

Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.

Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
Article: GENES CHROMOSOMES & CANCER. 2000;28(3):308-317

Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping.

Kytölä S; Rummukainen J; Nordgren A; Karhu R; Farnebo F; Isola J; Larsson C
Article: EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2000;142(6):643-649

Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas.

Frisk T; Farnebo F; Zedenius J; Grimelius L; Höög A; Wallin G; Larsson C
Article: MAMMALIAN GENOME. 2000;11(1):78-80

Molecular characterization of human and murine C11orf5, a new member of the FAUNA gene cluster.

Lemmens IH; Farnebo F; Piehl F; Merregaert J; Van de Ven WJ; Larsson C; Kas K
Article: HEMATOLOGY JOURNAL. 2000;1(2):95-101

Detailed characterization of a complex karyotype in a patient with primary plasma cell leukaemia using multicolour spectral karyotyping and micro-FISH.

Nordgren A; Farnebo F; Björkholm M; Sahlén S; Porwit-MacDonald A; Osby E; Kytölä S; Larsson C; Nordenskjöld M; Blennow E
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1999;84(10):3775-3780

Alternative genetic pathways in parathyroid tumorigenesis.

Farnebo F; Kytölä S; Teh BT; Dwight T; Wong FK; Höög A; Elvius M; Wassif WS; Thompson NW; Farnebo LO; Sandelin K; Larsson C
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1999;257(3):891-894

Restricted expression pattern of vegf-d in the adult and fetal mouse: high expression in the embryonic lung.

Farnebo F; Piehl F; Lagercrantz J
Article: CLINICAL ENDOCRINOLOGY. 1999;50(2):191-196

Genetic studies of a family with hereditary hyperparathyroidism-jaw tumour syndrome.

Wassif WS; Farnebo F; Teh BT; Moniz CF; Li FY; Harrison JD; Peters TJ; Larsson C; Harris P
Article: WORLD JOURNAL OF SURGERY. 1999;23(1):68-74

Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease.

Farnebo F; Auer G; Farnebo LO; Teh BT; Twigg S; Aspenblad U; Thompson NW; Grimelius L; Larsson C; Sandelin K
Article: CYTOGENETIC AND GENOME RESEARCH. 1999;87(3-4):225-232

Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.

Pan Y; Kytölä S; Farnebo F; Wang N; Lui WO; Nupponen N; Isola J; Visakorpi T; Bergerheim US; Larsson C
Article: ONCOGENE. 1998;17(19):2485-2493

Characterization of the mouse Men1 gene and its expression during development.

Stewart C; Parente F; Piehl F; Farnebo F; Quincey D; Silins G; Bergman L; Carle GF; Lemmens I; Grimmond S; Xian CZ; Khodei S; Teh BT; Lagercrantz J; Siggers P; Calender A; Van de Vem V; Kas K; Weber G; Hayward N; Gaudray P; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1998;83(8):2627-2630

Alterations of the MEN1 gene in sporadic parathyroid tumors.

Farnebo F; Teh BT; Kytölä S; Svensson A; Phelan C; Sandelin K; Thompson NW; Höög A; Weber G; Farnebo LO; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1998;83(8):2621-2626

Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism.

Teh BT; Kytölä S; Farnebo F; Bergman L; Wong FK; Weber G; Hayward N; Larsson C; Skogseid B; Beckers A; Phelan C; Edwards M; Epstein M; Alford F; Hurley D; Grimmond S; Silins G; Walters M; Stewart C; Cardinal J; Khodaei S; Parente F; Tranebjaerg L; Jorde R; Salmela P
Article: MAMMALIAN GENOME. 1998;9(8):660-665

Expression and chromosomal localization of the Requiem gene.

Gabig TG; Crean CD; Klenk A; Long H; Copeland NG; Gilbert DJ; Jenkins NA; Quincey D; Parente F; Lespinasse F; Carle GF; Gaudray P; Zhang CX; Calender A; Hoeppener J; Kas K; Thakker RV; Farnebo F; Teh BT; Larsson C; Piehl F; Lagercrantz J; Khodaei S; Carson E; Weber G
Article: ANNALS OF SURGERY. 1998;228(1):99-105

Thymic carcinoids in multiple endocrine neoplasia type 1.

Teh BT; Zedenius J; Kytölä S; Skogseid B; Trotter J; Choplin H; Twigg S; Farnebo F; Giraud S; Cameron D; Robinson B; Calender A; Larsson C; Salmela P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1998;247(2):357-360

Expression of the BCL6 gene in the pre- and postnatal mouse.

Bajalica-Lagercrantz S; Piehl F; Farnebo F; Larsson C; Lagercrantz J
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1998;1398(2):157-163

A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse.

Lagercrantz J; Farnebo F; Larsson C; Tvrdik T; Weber G; Piehl F
Article: GENOMICS. 1998;50(2):251-259

A putative human zinc-finger gene (ZFPL1) on 11q13, highly conserved in the mouse and expressed in exocrine pancreas. The European Consortium on MEN 1.

Höppener JW; De Wit MJ; Simarro-Doorten AY; Roijers JF; van Herrewaarden HM; Lips CJ; Parente F; Quincey D; Gaudray P; Khodaei S; Weber G; Teh B; Farnebo F; Larsson C; Zhang CX; Calender A; Pannett AA; Forbes SA; Bassett JH; Thakker RV; Lemmens I; Van de Ven WJ; Kas K
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1998;83(6):2114-2120

Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families.

Teh BT; Farnebo F; Twigg S; Höög A; Kytölä S; Korpi-Hyövälti E; Wong FK; Nordenström J; Grimelius L; Sandelin K; Robinson B; Farnebo LO; Larsson C
Article: MAMMALIAN GENOME. 1998;9(4):310-311

Mapping of the human Ca2+ channel beta 4 subunit to 2q22-23 and its expression in developing mouse.

Betz R; Leibiger B; Farnebo F; Lagercrantz S; Piehl F; Leibiger I; Larsson C
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1997;82(10):3481-3486

Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism.

Farnebo F; Enberg U; Grimelius L; Bäckdahl M; Schalling M; Larsson C; Farnebo LO
Article: GENOMICS. 1997;44(1):94-100

Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

Lemmens I; Merregaert J; Van de Ven WJ; Kas K; Zhang CX; Giraud S; Wautot V; Buisson N; De Witte K; Salandre J; Lenoir G; Calender A; Parente F; Quincey D; Courseaux A; Carle GF; Gaudray P; De Wit MJ; Lips CJ; Höppener JW; Khodaei S; Grant AL; Weber G; Kytölä S; Thakker RV
Article: HUMAN MOLECULAR GENETICS. 1997;6(7):1177-1183

Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.

Lemmens I; Van de Ven WJ; Kas K; Zhang CX; Giraud S; Wautot V; Buisson N; De Witte K; Salandre J; Lenoir G; Pugeat M; Calender A; Parente F; Quincey D; Gaudray P; De Wit MJ; Lips CJ; Höppener JW; Khodaei S; Grant AL; Weber G; Kytölä S; Teh BT; Farnebo F; Thakker RV
Article: BRITISH JOURNAL OF SURGERY. 1997;163(5):331-337

Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcaemic secondary hyperparathyroidism.

Farnebo F; Farnebo LO; Nordenström J; Larsson C
Article: HUMAN GENETICS. 1997;99(3):342-349

Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism.

Farnebo F; Teh BT; Dotzenrath C; Wassif WS; Svensson A; White I; Betz R; Goretzki P; Sandelin K; Farnebo LO; Larsson C
Article: CLINICAL GENETICS. 1997;51(1):52-55

Oculopharyngeal muscular dystrophy (OPMD)--report and genetic studies of an Australian kindred.

Teh BT; Sullivan AA; Farnebo F; Zander C; Li FY; Strachan N; Schalling M; Larsson C; Sandstrom P
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1996;81(12):4204-4211

Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas.

Teh BT; Farnebo F; Kristoffersson U; Sundelin B; Cardinal J; Axelson R; Yap A; Epstein M; Heath H; Cameron D; Larsson C
Article: GENOMICS. 1996;37(3):345-353

Definition of the Minimal MEN1 Candidate Area Based on a 5-Mb Integrated Map of Proximal 11q13.

Courseaux A; Grosgeorge J; Gaudray P; Pannett AAJ; Forbes SA; Williamson C; Bassett D; Thakker RV; Teh BT; Farnebo F; Shepherd J; Skogseid B; Larsson C; Giraud S; Zhang CX; Salandre J; Calender A
Article: GENOMICS. 1996;37(3):354-365

Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1).

Courseaux A; Grosgeorge J; Gaudray P; Pannett AA; Forbes SA; Williamson C; Bassett D; Thakker RV; Teh BT; Farnebo F; Shepherd J; Skogseid B; Larsson C; Giraud S; Zhang CX; Salandre J; Calender A
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1996;81(9):3194-3196

Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?

Dotzenrath C; Teh BT; Farnebo F; Cupisti K; Svensson A; Toell A; Goretzki P; Larsson C
Article: JOURNAL OF INTERNAL MEDICINE. 1995;238(3):239-244

Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1.

Larsson C; Calender A; Grimmond S; Giraud S; Hayward NK; Teh B; Farnebo F
Show more

All other publications

Letter: ARCHIVES OF SEXUAL BEHAVIOR. 2017;46(6):1573-1576

Craniofacial Reconstructive Surgery Improves Appearance Congruence in Male-to-Female Transsexual Patients.

Isung J; Möllermark C; Farnebo F; Lundgren K
Letter: ARCHIVES OF SEXUAL BEHAVIOR. 2016;45(8):1879-1880

Moving Transgender Care Forward within Public Health Organizations: Inclusion of Facial Feminizing Surgery in the Swedish National Treatment Recommendations.

Lundgren TK; Isung J; Rinder J; Dhejne C; Arver S; Holm L-E; Farnebo F
Corrigendum: ARCHIVES OF SEXUAL BEHAVIOR. 2016;45(8):1881

Erratum to: Moving Transgender Care Forward within Public Health Organizations: Inclusion of Facial Feminizing Surgery in the Swedish National Treatment Recommendations.

Lundgren TK; Isung J; Rinder J; Dhejne C; Arver S; Holm L-E; Farnebo F
Letter: PLASTIC AND RECONSTRUCTIVE SURGERY. 2012;129(3):549e-550e

Does previous head and neck irradiation increase vascular complications in free autologous reconstruction?

Halle M; Farnebo F
Published conference paper: JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY. 2009;62(7):889-895

Timing of radiotherapy in head and neck free flap reconstruction--a study of postoperative complications.

Halle M; Bodin I; Tornvall P; Wickman M; Farnebo F; Arnander C
Letter: LAKARTIDNINGEN. 2005;102(14):1079

[Late skin infections following tsunami injuries].

Petrini B; Farnebo F; Appelgren P
Published conference paper: SURGERY. 2002;132(5):857-865

Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.

Tseng JF; Farnebo FA; Kisker O; Becker CM; Kuo CJ; Folkman J; Mulligan RC
Published conference paper: SURGERY. 1999;126(6):1183-1187

Expression of matrix metalloproteinase gelatinase A messenger ribonucleic acid in parathyroid carcinomas.

Farnebo F; Svensson A; Thompson NW; Bäckdahl M; Grimelius L; Larsson C; Farnebo LO; Sandelin K
Meeting abstract: PEDIATRIC RESEARCH. 1999;45(4):144A

Characterization of chromosomal changes in 17 children with acute lymphoblastic leukemia and hyperdiploidy using spectral karyotyping (SKY)

Blennow E; Nordgren A; Farnebo F; Soderhall S; Nordenskjold M
Published conference paper: SURGERY. 1998;124(6):1094-1098

Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas.

Farnebo F; Höög A; Sandelin K; Larsson C; Farnebo LO
Letter: AMERICAN JOURNAL OF HUMAN GENETICS. 1998;63(5):1544-1549

A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors.

Teh BT; Esapa CT; Houlston R; Grandell U; Farnebo F; Nordenskjöld M; Pearce CJ; Carmichael D; Larsson C; Harris PE
Published conference paper: JOURNAL OF INTERNAL MEDICINE. 1998;243(6):441-446

The search for the MEN1 gene. The European Consortium on MEN-1.
Editorial comment: SURGERY. 1998;124(6):1098-1099

Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas - Discussion

McHenry CR; Farnebo F; Marx S; Akerstrom G; Mitchell BK
Published conference paper: HORMONE RESEARCH IN PAEDIATRICS. 1997;47(4-6):179-184

Multiple endocrine neoplasia type 1 and the search for the genetic trigger.

Farnebo F; Järhult J; Farnebo LO; Nilsson O; Teh BT; Lagercrantz J; Weber G; Sandelin K; Larsson C
Published conference paper: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. 1996;104 Suppl 4:105-107

Molecular genetics of primary and secondary hyperparathyroidism.

Dotzenrath C; Goretzki PE; Farnebo F; Teh BT; Weber G; Röher HD; Larsson C

Employments

Affiliated to Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2023-2026

Degrees and Education

Docent, Karolinska institutet, 2004
University Medical Degree, Karolinska Institutet, 2001
Doctor Of Philosophy, Department of Molecular Medicine and Surgery, Karolinska Institutet, 1998

Research

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI